Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shang Li

Showing results (681-690 of 690) with videos related to

Pageof 69
Sort By:
You have reached the last page of results.This site can display upto 690 results.
Annals of Surgery|November 3, 2025
Association of Recurrence with a Tumor-informed Personalized ctDNA Detection Approach in Resectable Colorectal Cancer: Results of a Prospective Observational StudyDi Cao, Guang-Zhao Lv, Cong Li, et al.
Nature Communications|September 29, 2016
Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneityWen Fong Ooi, Manjie Xing, Chang Xu, et al.
Cancer Cell|April 11, 2025
Neoadjuvant toripalimab plus nimotuzumab combined with taxol-based chemotherapy in locally advanced penile squamous cell carcinomaXin An, Sheng Jie Guo, Ru Yan, et al.
Cancer Discovery|September 13, 2017
<i>VHL</i> Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell CarcinomaXiaosai Yao, Jing Tan, Kevin Junliang Lim, et al.
Nature Cell Biology|April 24, 2023
PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinomaXiaosai Yao, Jing Han Hong, Amrita M Nargund, et al.
Science Translational Medicine|April 1, 2026
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancersJing Han Hong, Chern Han Yong, Hong Lee Heng, et al.
Gut|March 14, 2023
Comprehensive molecular phenotyping of <i>ARID1A</i>-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunitiesChang Xu, Kie Kyon Huang, Jia Hao Law, et al.
Ebiomedicine|July 19, 2016
Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic LeukemiaYuan-Fang Liu, Bai-Yan Wang, Wei-Na Zhang, et al.
The Journal of Clinical Investigation|May 5, 2020
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancerManjie Xing, Wen Fong Ooi, Jing Tan, et al.
Signal Transduction and Targeted Therapy|December 23, 2024
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trialJia Zhong, Kailun Fei, Lin Wu, et al.
Pageof 69

Showing results (681-690 of 690) with videos related to

Sort By:
Pageof 69
You have reached the last page of results.This site can display upto 690 results.
Annals of Surgery|November 3, 2025
Association of Recurrence with a Tumor-informed Personalized ctDNA Detection Approach in Resectable Colorectal Cancer: Results of a Prospective Observational StudyDi Cao, Guang-Zhao Lv, Cong Li, et al.
Nature Communications|September 29, 2016
Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneityWen Fong Ooi, Manjie Xing, Chang Xu, et al.
Cancer Cell|April 11, 2025
Neoadjuvant toripalimab plus nimotuzumab combined with taxol-based chemotherapy in locally advanced penile squamous cell carcinomaXin An, Sheng Jie Guo, Ru Yan, et al.
Cancer Discovery|September 13, 2017
<i>VHL</i> Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell CarcinomaXiaosai Yao, Jing Tan, Kevin Junliang Lim, et al.
Nature Cell Biology|April 24, 2023
PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinomaXiaosai Yao, Jing Han Hong, Amrita M Nargund, et al.
Science Translational Medicine|April 1, 2026
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancersJing Han Hong, Chern Han Yong, Hong Lee Heng, et al.
Gut|March 14, 2023
Comprehensive molecular phenotyping of <i>ARID1A</i>-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunitiesChang Xu, Kie Kyon Huang, Jia Hao Law, et al.
Ebiomedicine|July 19, 2016
Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic LeukemiaYuan-Fang Liu, Bai-Yan Wang, Wei-Na Zhang, et al.
The Journal of Clinical Investigation|May 5, 2020
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancerManjie Xing, Wen Fong Ooi, Jing Tan, et al.
Signal Transduction and Targeted Therapy|December 23, 2024
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trialJia Zhong, Kailun Fei, Lin Wu, et al.
Pageof 69